References
- Allen AP, Dinan TG, Clarke G, Cryan JF. 2017. A psychology of the human brain-gut-microbiome axis. Soc Personal Psychol Compass. 11:e12309Apr
- Bahr SM, Tyler BC, Wooldridge N, Butcher BD, Burns TL, Teesch LM, Oltman CL, Azcarate-Peril MA, Kirby JR, Calarge CA. 2015. Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children. Transl Psychiatry. 5:e652.
- Bastiaanssen TFS, Cowan CSM, Claesson MJ, Dinan TG, Cryan JF. 2018. Making sense of … the microbiome in psychiatry. Int J Neuropsychopharmacol. doi: 10.1093/ijnp/pyy067. [Epub ahead of print]
- Brainstorm Consortium, Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J, Duncan L, Escott-Price V, Falcone GJ, Gormley P, et al. 2018. Analysis of shared heritability in common disorders of the brain. Science. 360: pii: eaap8757.
- Cussotto S, Strain CR, Fouhy F, Strain RG, Peterson VL, Clarke G, Stanton C, Dinan TG, Cryan JF. 2018. Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function. Psychopharmacology (Berl). doi:10.1007/s00213-018-5006-5 [Epub ahead of print].
- Davey KJ, Cotter PD, O'Sullivan O, Crispie F, Dinan TG, Cryan JF, O'Mahony SM. 2013. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry. 3:e309.
- Davey KJ, O’Mahony SM, Schellekens H, O’Sullivan O, Bienenstock J, Cotter PD, Dinan TG, Cryan JF. 2012. Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology (Berl). 221:155–169.
- Dinan T, Borre Y, Cryan JF. 2014. Genomics of schizophrenia: time to consider the gut microbiome. Mol Psychiatry. 19:1252–1257.
- Flowers SA, Evans SJ, Ward KM, Mcinnis MG, Ellingrod VL. 2017. Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort. Pharmacotherapy 37:261–267.
- Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Möller HJ. WFSBP Task force on Treatment Guidelines for Schizophrenia. 2013. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry. 14:2–44.
- Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Möller HJ World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia.. 2012. , World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 13:318–378.
- Kao AC, Burnet PWJ, Lennox BR. 2018. Can prebiotics assist in the management of cognition and weight gain in schizophrenia? Psychoneuroendocrinology 95:179–185.
- Kristiansen JE, Mortensen I. 1987. Antibacterial effect of four phenothiazines. Pharmacol Toxicol. 60:100–103.
- Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, et al. 2018. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555:623–628.
- Nehme H, Saulnier P, Ramadan AA, Cassisa V, Guillet C, Eveillard M, Umerska A. 2018. Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity. PLoS One. 13:e0189950.
- Rodrigues-Amorim D, Rivera-Baltanás T, Regueiro B, Spuch C, DE LAS Heras ME, Vázquez-Noguerol Méndez R, Nieto-Araujo M, Barreiro-Villar C, Olivares JM, Agís-Balboa RC. 2018. The role of the gut microbiota in schizophrenia: current and future perspectives. World J Biol Psychiatry. 19:571-585.